May 8
|
Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
|
May 8
|
Avadel Pharmaceuticals PLC (AVDL) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
|
May 7
|
Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight
|
May 7
|
Avadel: Q1 Earnings Snapshot
|
May 7
|
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
|
May 6
|
Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction
|
Feb 24
|
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
|
Feb 20
|
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
|
Jan 3
|
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
|
Aug 28
|
Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug
|
Aug 28
|
Avadel Pharmaceuticals plc (AVDL): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
Jun 21
|
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
|
May 22
|
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
|
May 21
|
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
|
May 9
|
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript
|
May 8
|
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...
|
May 8
|
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 1
|
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8
|
Apr 29
|
Wall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should Know
|
Apr 21
|
11 Best Low Price Pharma Stocks To Invest In
|